Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
publications [2020/01/10 10:02] ramirez [2019] |
publications [2020/03/06 14:05] ramirez [2020] |
||
---|---|---|---|
Line 2: | Line 2: | ||
===== 2020 ===== | ===== 2020 ===== | ||
+ | [[people:cmendes|Mendes CI]],Lizarazo E, Machado MP, Silva DN, Tami A, [[people:ramirez|Ramirez M]], Couto N, Rossen JWA, Carriço JA. 2020. <fc #0000FF>DEN-IM: dengue virus genotyping from amplicon and shotgun metagenomic sequencing</fc>. Microbial Genomics. [[http://www.ncbi.nlm.nih.gov/pubmed/32134380|(PMID: 32134380)]] | ||
+ | |||
+ | van der Linden M, Mamede R, Levina N, Helwig P, Vila-Cerqueira P, Carriço JA, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], [[people:emartins|Martins ER]]. 2020. <fc #0000FF>Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany</fc>. J Antimicrob Chemother. 75:296–299. [[http://www.ncbi.nlm.nih.gov/pubmed/31740946|(PMID: 31740946)]] | ||
+ | |||
Hänscheid T, Grobusch MP. 2020. <fc #0000FF>Coenzyme Q10 and cerebral malaria in mice: Questionable interpretations, improbable usefulness in humans</fc>. Parasitol Int 74:101969. [[http://www.ncbi.nlm.nih.gov/pubmed/31421269|(PMID: 31421269)]] | Hänscheid T, Grobusch MP. 2020. <fc #0000FF>Coenzyme Q10 and cerebral malaria in mice: Questionable interpretations, improbable usefulness in humans</fc>. Parasitol Int 74:101969. [[http://www.ncbi.nlm.nih.gov/pubmed/31421269|(PMID: 31421269)]] | ||
Line 8: | Line 12: | ||
Hänscheid T, Schlagenhauf P, Grobusch MP. 2019. Atovaquone/proguanil for malaria chemoprophylaxis - Could a difference in susceptibility during hepatic development explain the need to continue drug intake for 7 days post-exposure? Travel Med Infect Dis 101527. [[http://www.ncbi.nlm.nih.gov/pubmed/31759143|(PMID: 31759143)]] | Hänscheid T, Schlagenhauf P, Grobusch MP. 2019. Atovaquone/proguanil for malaria chemoprophylaxis - Could a difference in susceptibility during hepatic development explain the need to continue drug intake for 7 days post-exposure? Travel Med Infect Dis 101527. [[http://www.ncbi.nlm.nih.gov/pubmed/31759143|(PMID: 31759143)]] | ||
- | |||
- | van der Linden M, Mamede R, Levina N, Helwig P, Vila-Cerqueira P, Carriço JA, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], [[people:emartins|Martins ER]]. 2019. <fc #0000FF>Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany</fc>. J Antimicrob Chemother. //In press//. [[http://www.ncbi.nlm.nih.gov/pubmed/31740946|(PMID: 31740946)]] | ||
Duque-Valencia J, Forero-Muñoz NR, Díaz FJ, [[people:emartins|Martins E]], Barato P, Ruiz-Saenz J. 2019. <fc #0000FF>Phylogenetic evidence of the intercontinental circulation of a canine distemper virus lineage in the Americas</fc>. Sci Rep 9:15747. [[http://www.ncbi.nlm.nih.gov/pubmed/31673120|(PMID: 31673120)]] | Duque-Valencia J, Forero-Muñoz NR, Díaz FJ, [[people:emartins|Martins E]], Barato P, Ruiz-Saenz J. 2019. <fc #0000FF>Phylogenetic evidence of the intercontinental circulation of a canine distemper virus lineage in the Americas</fc>. Sci Rep 9:15747. [[http://www.ncbi.nlm.nih.gov/pubmed/31673120|(PMID: 31673120)]] | ||
Line 37: | Line 39: | ||
Björnsdóttir ES, [[people:emartins|Martins ER]], Erlendsdóttir H, Haraldsson G, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], Kristinsson KG. 2019. <fc #0000FF>Group B streptococcal neonatal and early infancy infections in Iceland 1976 - 2015</fc>. Pediatr Infect Dis J. 38:620–624. [[http://www.ncbi.nlm.nih.gov/pubmed/30299423|(PMID: 30299423)]] | Björnsdóttir ES, [[people:emartins|Martins ER]], Erlendsdóttir H, Haraldsson G, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], Kristinsson KG. 2019. <fc #0000FF>Group B streptococcal neonatal and early infancy infections in Iceland 1976 - 2015</fc>. Pediatr Infect Dis J. 38:620–624. [[http://www.ncbi.nlm.nih.gov/pubmed/30299423|(PMID: 30299423)]] | ||
- | Huizenga E, van der Ende J, Zwinkels N, Jimissa A, van der Ende-Bouwman C, van Rooijen R, Kargbo B, Agnandji ST, Hänscheid T, Goorhuis A, Grobusch MP. 2018. <fc #0000FF>A modified case definition to facilitate essential hospital care during Ebola outbreaks</fc>. Clin Infect Dis. 68:1763–1768. [[http://www.ncbi.nlm.nih.gov/pubmed/30239602|(PMID: 30239602)]] | + | Huizenga E, van der Ende J, Zwinkels N, Jimissa A, van der Ende-Bouwman C, van Rooijen R, Kargbo B, Agnandji ST, Hänscheid T, Goorhuis A, Grobusch MP. 2019. <fc #0000FF>A modified case definition to facilitate essential hospital care during Ebola outbreaks</fc>. Clin Infect Dis. 68:1763–1768. [[http://www.ncbi.nlm.nih.gov/pubmed/30239602|(PMID: 30239602)]] |
+ | |||
+ | Hänscheid T, Grobusch MP. 2019. <fc #0000FF>Could antibiotic treatment of traveller’s diarrhoea even prolong elimination of pathogens?</fc> Travel Med Infect Dis. 28:104. [[http://www.ncbi.nlm.nih.gov/pubmed/30030070|(PMID: 30030070)]] | ||
===== 2018 ===== | ===== 2018 ===== | ||
Caneiras C, Calisto F, Jorge da Silva G, Lito L, [[people:jmelocristino|Melo-Cristino J]], Duarte A. 2018. <fc #0000FF>First description of colistin and tigecycline-resistant //Acinetobacter baumannii// producing KPC-3 carbapenemase in Portugal</fc>. Antibiotics 7. [[https://doi.org/10.3390/antibiotics7040096|doi:10.3390/antibiotics7040096]] [[http://www.ncbi.nlm.nih.gov/pubmed/30404152|(PMID: 30404152)]] | Caneiras C, Calisto F, Jorge da Silva G, Lito L, [[people:jmelocristino|Melo-Cristino J]], Duarte A. 2018. <fc #0000FF>First description of colistin and tigecycline-resistant //Acinetobacter baumannii// producing KPC-3 carbapenemase in Portugal</fc>. Antibiotics 7. [[https://doi.org/10.3390/antibiotics7040096|doi:10.3390/antibiotics7040096]] [[http://www.ncbi.nlm.nih.gov/pubmed/30404152|(PMID: 30404152)]] | ||
Line 52: | Line 56: | ||
Branco A, Francisco D, Hänscheid T. 2018. <fc #0000FF>Is there a “normal” oxygen concentration for in vitro //Plasmodium// cultures?</fc> Trends Parasitol 34:811–812. [[http://www.ncbi.nlm.nih.gov/pubmed/30049603|(PMID: 30049603)]] | Branco A, Francisco D, Hänscheid T. 2018. <fc #0000FF>Is there a “normal” oxygen concentration for in vitro //Plasmodium// cultures?</fc> Trends Parasitol 34:811–812. [[http://www.ncbi.nlm.nih.gov/pubmed/30049603|(PMID: 30049603)]] | ||
- | |||
- | |||
- | Hänscheid T, Grobusch MP. 2018. <fc #0000FF>Could antibiotic treatment of traveller’s diarrhoea even prolong elimination of pathogens?</fc> Travel Med Infect Dis. //In press// [[http://www.ncbi.nlm.nih.gov/pubmed/30030070|(PMID: 30030070)]] | ||
Couto N, Schuele L, Raangs EC, [[people:mpmachado|Machado MP]], [[people:cmendes|Mendes CI]], Jesus TF, Chlebowicz M, Rosema S, [[people:ramirez|Ramirez M]],[[people:jcarrico|Carriço JA]], Autenrieth IB, Friedrich AW, Peter S, Rossen JW.<fc #0000FF> Critical steps in clinical shotgun metagenomics for the concomitant detection and typing of microbial pathogens</fc>. Sci Rep. 2018 Sep 13;8(1):13767. doi: 10.1038/s41598-018-31873-w.[[http://www.ncbi.nlm.nih.gov/pubmed/30213965 |(PMID: 30213965)]] | Couto N, Schuele L, Raangs EC, [[people:mpmachado|Machado MP]], [[people:cmendes|Mendes CI]], Jesus TF, Chlebowicz M, Rosema S, [[people:ramirez|Ramirez M]],[[people:jcarrico|Carriço JA]], Autenrieth IB, Friedrich AW, Peter S, Rossen JW.<fc #0000FF> Critical steps in clinical shotgun metagenomics for the concomitant detection and typing of microbial pathogens</fc>. Sci Rep. 2018 Sep 13;8(1):13767. doi: 10.1038/s41598-018-31873-w.[[http://www.ncbi.nlm.nih.gov/pubmed/30213965 |(PMID: 30213965)]] |